- Home
- TNGX vs SAR Comparison
TNGX vs SAR Comparison
Compare TNGX & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- SAR
- Stock Information
- Founded
- TNGX 2014
- SAR 2007
- Country
- TNGX United States
- SAR United States
- Employees
- TNGX N/A
- SAR N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- SAR Investment Managers
- Sector
- TNGX Health Care
- SAR Finance
- Exchange
- TNGX Nasdaq
- SAR Nasdaq
- Market Cap
- TNGX 317.4M
- SAR 337.6M
- IPO Year
- TNGX N/A
- SAR 2007
- Fundamental
- Price
- TNGX $1.14
- SAR $23.43
- Analyst Decision
- TNGX Strong Buy
- SAR Buy
- Analyst Count
- TNGX 7
- SAR 4
- Target Price
- TNGX $12.33
- SAR $25.08
- AVG Volume (30 Days)
- TNGX 532.3K
- SAR 88.4K
- Earning Date
- TNGX 05-12-2025
- SAR 05-07-2025
- Dividend Yield
- TNGX N/A
- SAR 14.13%
- EPS Growth
- TNGX N/A
- SAR 186.33
- EPS
- TNGX N/A
- SAR 2.02
- Revenue
- TNGX $42,069,000.00
- SAR $148,855,238.00
- Revenue This Year
- TNGX N/A
- SAR $6.07
- Revenue Next Year
- TNGX N/A
- SAR N/A
- P/E Ratio
- TNGX N/A
- SAR $11.64
- Revenue Growth
- TNGX 15.17
- SAR 3.57
- 52 Week Low
- TNGX $1.11
- SAR $21.10
- 52 Week High
- TNGX $12.02
- SAR $26.49
- Technical
- Relative Strength Index (RSI)
- TNGX 36.06
- SAR 44.44
- Support Level
- TNGX $1.03
- SAR $22.22
- Resistance Level
- TNGX $1.56
- SAR $25.11
- Average True Range (ATR)
- TNGX 0.15
- SAR 0.56
- MACD
- TNGX -0.01
- SAR -0.05
- Stochastic Oscillator
- TNGX 17.74
- SAR 37.54
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About SAR Saratoga Investment Corp New
Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.